Podcast Episodes

Back to Search
PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting
PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting

Episode 222

In this podcast episode, Jeremy S. Abramson, MD, MMSc, reviews data from select presentations in lymphomas at the ASH 2025 Annual Meeting and provide…

3 months, 3 weeks ago

Short Long
View Episode
PulseCast: Highlights in Nonmalignant Blood Disorders From the 2025 ASH Annual Meeting
PulseCast: Highlights in Nonmalignant Blood Disorders From the 2025 ASH Annual Meeting

Episode 221

In this episode, Hanny Al-Samkari, MD, gives his thoughts on 5 key presentations from ASH 2025, and provides perspectives on the clinical implication…

3 months, 3 weeks ago

Short Long
View Episode
PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting
PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting

Episode 220

In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspect…

3 months, 4 weeks ago

Short Long
View Episode
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?

Episode 219

In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treat…

4 months, 3 weeks ago

Short Long
View Episode
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer

Episode 218

In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent…

5 months, 1 week ago

Short Long
View Episode
CDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach
CDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach

Episode 217

In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conju…

5 months, 1 week ago

Short Long
View Episode
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care

Episode 216

In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for…

5 months, 2 weeks ago

Short Long
View Episode
Paroxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management
Paroxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management

Episode 215

In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal…

5 months, 2 weeks ago

Short Long
View Episode
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Episode 214

In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-n…

6 months ago

Short Long
View Episode
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer

Episode 213

In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-n…

6 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us